REGISTERED NUMBER: 11327810 (England and Wales)

DIRECTOR'S REPORT AND

AUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST DECEMBER 2025

FOR

UNITED IMAGING HEALTHCARE UK LTD.

Page

Company Information

1

Director's Report

2

Report of the Independent Auditors

4

Income Statement

7

Other Comprehensive Income

8

Statement of Financial Position

9

Statement of Changes in Equity

10

Notes to the Financial Statements

11

DIRECTOR:

J Gao

REGISTERED OFFICE:

Vintage House

Albert Embankment

London

SE1 7TL

REGISTERED NUMBER:

11327810 (England and Wales)

INDEPENDENT AUDITORS:

Watergates Ltd (Statutory Auditor)

109 Coleman Road

Leicester

Leicestershire

LE5 4LE

The director presents her report with the financial statements of the Company for the year ended 31st December 2025.

PRINCIPAL ACTIVITY

The principal activity of the Company in the year under review was that of activities of distribution holding companies.

DIVIDENDS

No dividends will be distributed for the year ended 31st December 2025.

DIRECTORS

The directors who have held office during the period from 1st January 2025 to the date of this report are as follows:

F Xia - resigned 11th March 2025

Y Yu - resigned 11th March 2025

J Gao - appointed 11th March 2025

STATEMENT OF DIRECTOR'S RESPONSIBILITIES

The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the director must not approve the financial statements unless she is satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period. In preparing these financial statements, the director is required to:

-	select suitable accounting policies and then apply them consistently;

-	make judgements and accounting estimates that are reasonable and prudent;

-	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable her to ensure that the financial statements comply with the Companies Act 2006. She is also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the Company's auditors are unaware, and she has taken all the steps that she ought to have taken as a director in order to make herself aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

AUDITORS

The auditors, Watergates Ltd (Statutory Auditor), will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:

J Gao - Director

19th October 2026

Opinion

We have audited the financial statements of United Imaging Healthcare Uk Ltd. (the 'Company') for the year ended 31st December 2025 which comprise the Income Statement, Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

-	give a true and fair view of the state of the Company's affairs as at 31st December 2025 and of its profit for the year then ended;

-	have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

-	have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information

The director is responsible for the other information. The other information comprises the information in the Director's Report, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

-	the information given in the Director's Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

-	the Director's Report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Director's Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

-	adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

-	the financial statements are not in agreement with the accounting records and returns; or

-	certain disclosures of director's remuneration specified by law are not made; or

-	we have not received all the information and explanations we require for our audit.

Responsibilities of director

As explained more fully in the Statement of Director's Responsibilities set out on page two, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Irregularities are instances of non-compliance with laws and regulations. The objectives of our audit are to obtain sufficient appropriate audit evidence regarding compliance with laws and regulations that have a direct effect on the determination of material amounts and disclosures in the financial statements, to perform audit procedures to help identify instances of non-compliance with other laws and regulations that may have a material effect on the financial statements, and to respond appropriately to identified or suspected non-compliance with laws and regulations identified during the audit.

In relation to fraud, the objectives of our audit are to identify and assess the risk of material misstatement of the financial statements due to fraud, to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud through designing and implementing appropriate responses and to respond appropriately to fraud or suspected fraud identified during the audit.

However, it is the primary responsibility of management, with the oversight of those charged with governance, to ensure that the entity's operations are conducted in accordance with the provisions of laws and regulations and for the prevention and detection of fraud.

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud, the audit engagement team:

- obtained an understanding of the nature of the industry and sector, including the legal and regulatory framework that the company operates in and how the company is complying with the legal and regulatory framework;

- inquired of management, and those charged with governance, about their own identification and assessment of the risks of irregularities, including any known actual, suspected or alleged instances of fraud;

- discussed matters about non-compliance with laws and regulations and how fraud might occur including assessment of how and where the financial statements may be susceptible to fraud.

As a result of these procedures we consider the most significant laws and regulations that have a direct impact on the financial statements are FRS 102, the Companies Act 2006 and tax compliance regulations. We performed audit procedures to detect non-compliances which may have a material impact on the financial statements which included reviewing financial statement disclosures, inspecting correspondence with local tax authorities and evaluating advice received from external tax advisors.

The most significant laws and regulations that have an indirect impact on the financial statements are those in relation to employment regulations. We performed audit procedures to inquire of management and those charged with governance whether the company is in compliance with these laws and regulations and inspected correspondence with regulatory authorities as appropriate.

The audit engagement team identified the risk of management override of controls as the area where the financial statements were most susceptible to material misstatement due to fraud. Audit procedures performed included but were not limited to testing manual journal entries and other adjustments and evaluating the business rationale in relation to significant, unusual transactions and transactions entered into outside the normal course of business.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Nazir Malida FCCA (Senior Statutory Auditor)

for and on behalf of Watergates Ltd (Statutory Auditor)

109 Coleman Road

Leicester

Leicestershire

LE5 4LE

19th October 2026

TURNOVER

-

-

Administrative expenses

(708,463

)

(428,600

)

OPERATING LOSS

4

(708,463

)

(428,600

)

Gain/loss on revaluation of investments

5,464,273

(22,366,714

)

PROFIT/(LOSS) BEFORE TAXATION

4,755,810

(22,795,314

)

Tax on profit/(loss)

5

-

-

PROFIT/(LOSS) FOR THE FINANCIAL YEAR

4,755,810

(22,795,314

)

PROFIT/(LOSS) FOR THE YEAR

4,755,810

(22,795,314

)

OTHER COMPREHENSIVE INCOME

-

-

TOTAL COMPREHENSIVE INCOME/(LOSS) FOR THE YEAR

4,755,810

(22,795,314

)

FIXED ASSETS

Investments

7

225,477,347

210,687,019

CURRENT ASSETS

Debtors

8

33,502

26,068

Cash at bank and in hand

183,410

307,981

216,912

334,049

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

9

(93,383

)

(76,002

)

NET CURRENT ASSETS

123,529

258,047

TOTAL ASSETS LESS CURRENT LIABILITIES

225,600,876

210,945,066

CAPITAL AND RESERVES

Called up share capital

10

646,943

646,943

Share premium

11

243,244,557

233,344,557

Non-distributable retained earnings

11

(16,902,441

)

(22,366,714

)

Retained earnings

11

(1,388,183

)

(679,720

)

SHAREHOLDERS' FUNDS

225,600,876

210,945,066

The financial statements were approved by the director and authorised for issue on 19th October 2026 and were signed by:

J Gao - Director

Called up

Non-distributable

share

Retained

Share

retained

Total

capital

earnings

premium

earnings

equity

$

$

$

$

$

Balance at 1st January 2024

646,943

(251,120

)

187,494,557

-

187,890,380

Changes in equity

Total comprehensive loss

-

(22,795,314

)

-

-

(22,795,314

)

Additional paid in capital

-

-

45,850,000

-

45,850,000

Transfer between reserves

-

22,366,714

-

(22,366,714

)

-

Balance at 31st December 2024

646,943

(679,720

)

233,344,557

(22,366,714

)

210,945,066

Changes in equity

Total comprehensive income

-

4,755,810

-

-

4,755,810

Additional paid in capital

-

-

9,900,000

-

9,900,000

Transfer between reserves

-

(5,464,273

)

-

5,464,273

-

Balance at 31st December 2025

646,943

(1,388,183

)

243,244,557

(16,902,441

)

225,600,876

1.	STATUTORY INFORMATION

United Imaging Healthcare Uk Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the US Dollar ($).

2.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

FINANCIAL REPORTING STANDARD 102 - REDUCED DISCLOSURE EXEMPTIONS

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

•

the requirements of Section 7 Statement of Cash Flows;

•

the requirement of paragraph 3.17(d);

•

the requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);

•

the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A;

•

the requirements of paragraphs 26.18(b), 26.19 to 26.21 and 26.23;

•

the requirement of paragraph 33.7;

•

the requirements of paragraph 24(b) of IFRS 6.

This information is included in the consolidated financial statements of Shanghai United Imaging Healthcare Co. Ltd as at 31st December 2025 and these financial statements may be obtained from 2258 Cheng Bei Rd., Shanghai, China, 201807.

PREPARATION OF CONSOLIDATED FINANCIAL STATEMENTS

The Company is exempt under Section 401 of the Companies Act 2006 from the requirements to prepare consolidated financial statements as the Company is included in the consolidated financial statements of its parent, Shanghai United Imaging Healthcare Co. Ltd, and these financial statements may be obtained from 2258 Cheng Bei Rd., Shanghai, China, 201807.

GOING CONCERN

As the entity is not trading there is very little by way of activity, and after considering all relevant uncertainties, the directors have a reasonable expectation that the company has adequate resources to continue as a going concern for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.

The company acts as an intermediary parent using liquid resources provided by its ultimate parent who ensure there is sufficient liquidity available to meet any foreseeable needs.

INVESTMENTS IN SUBSIDIARIES

Investments in subsidiary undertakings are recognised at cost.

TAXATION

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

DEFERRED TAX

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

FOREIGN CURRENCIES

Assets and liabilities in foreign currencies are translated into USD at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into USD at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

31/12/25

31/12/24

$

$

Wages and salaries

405,681

246,104

Social security costs

52,614

2,298

Other pension costs

2,757

2,802

461,052

251,204

The average number of employees during the year was as follows:

31/12/25

31/12/24

Employees

4

2

31/12/25

31/12/24

$

$

Directors' remuneration

-

-

4.	OPERATING PROFIT/(LOSS)

The operating profit (2024 - operating loss) is stated after charging:

31/12/25

31/12/24

$

$

Auditors' remuneration

15,120

14,464

Foreign exchange differences

8,981

10,591

5.

TAXATION

Analysis of the tax charge

No liability to UK corporation tax arose for the year ended 31st December 2025 nor for the year ended 31st December 2024.

6.	PRIOR YEAR ADJUSTMENT

A prior year adjustment has been made in respect of the year ended 31 December 2024 to reflect a transfer between reserves relating to the revaluation loss recognised during 2024. The adjustment represents a presentational reclassification between reserves, and the underlying revaluation was correctly recognised in the prior year. As a result, Retained Earnings have increased by $22.4m, with a corresponding decrease of $22.4m in Non-distributable Retained Earnings. The prior year adjustment has no impact on the total shareholders’ funds, profit for the year, or net assets, and only affects the presentation of the reserves.

7.	FIXED ASSET INVESTMENTS

Shares in

group

undertaking

$

COST

At 1st January 2025

210,687,019

Additions

9,326,055

Reversal of impairments

5,464,273

At 31st December 2025

225,477,347

NET BOOK VALUE

At 31st December 2025

225,477,347

At 31st December 2024

210,687,019

The share in group undertaking represents United Imaging Healthcare Uk Ltd holding:

100% of the issued share capital of UIH America Inc, a USA registered company.

100% of the issued share capital of United Imaging Healthcare (Australia & New Zealand) PTY Ltd, an Australian registered company.

100% of the issued share capital of United Imaging Healthcare Poland SP. Z O.O., a Polish registered company.

100% of the issued share capital of United Imaging Healthcare Japan, a Japanese registered company.

100% of the issued share capital of United Imaging Healthcare Southern Africa (Proprietary) Limited, a South African registered company.

100% of the issued share capital of United Imaging Healthcare Columbia, a Columbian registered company.

100% of the issued share capital of United Imaging Healthcare Italy, an Italian registered company.

100% of the issued share capital of United Imaging Healthcare France, a French registered company.

100% of the issued share capital of United Imaging Healthcare Germany, a German registered company.

8.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31/12/25

31/12/24

$

$

Amounts owed by group undertakings

-

26,068

VAT

33,502

-

33,502

26,068

9.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31/12/25

31/12/24

$

$

Trade creditors

193

182

Amounts owed to group undertakings

6,022

6,022

VAT

-

1,735

Accruals and deferred income

87,168

68,063

93,383

76,002

10.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31/12/25

31/12/24

value:

$

$

500,000

Ordinary

1.29

646,943

646,943

11.

RESERVES

Non-distributable

Retained

Share

retained

earnings

premium

earnings

Totals

$

$

$

$

At 1st January 2025

(679,720

)

233,344,557

(22,366,714

)

210,298,123

Profit for the year

4,755,810

4,755,810

Additional paid in capital

-

9,900,000

-

9,900,000

Transfer between reserves

(5,464,273

)

-

5,464,273

-

At 31st December 2025

(1,388,183

)

243,244,557

(16,902,441

)

224,953,933

Retained earnings

Retained earnings represents cumulative profits and losses net of dividends paid and other adjustments.

Share premium

Share premium represents additional paid-in capital for contributions made by the parent company. No new shares were issued in respect of these contributions. The amount has been credited directly to equity and is non-distributable.

Non-distributable retained earnings

The non-distributable element of retained earnings represents unrealised gains arising from the revaluation of investments to fair value at the reporting date. These amounts are not considered realised profits and, accordingly, are not available for distribution. The balance will only become distributable when the underlying investments are disposed of and the gains are realised. This has been shown separately as non-distributable retained earnings for presentational purposes only, but falls part of the retained earnings.

12.	RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

It is the opinion of the directors that there are no members of key management personnel other than

the directors themselves.

All transactions are conducted on an arm's length basis.

13.	ULTIMATE CONTROLLING PARENT

The Company's immediate and ultimate parent undertaking is Shanghai United Imaging Healthcare Co. Ltd which is registered in China.